Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 34,892 shares at $37.01 ($229K) on 2015-02-02, disclosed to the SEC on 2015-02-03.
Scheduled sale ($229k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 28,643 | $0 | 0.0% |
| 2 | $36.36 | 2,949 | $107K | 46.8% |
| 3 | $37.01 | 3,300 | $122K | 53.2% |
| Total | $6.57 avg | 34,892 | $229K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |